Given that childhood cancers are all rare or ultra-rare diseases, the ability of the biopharmaceutical industry to invest resources into development of new treatments is limited at best. Yet research is needed to identify potential targets for the entire spectrum of childhood cancers.
鉴于儿童癌症的罕见或超罕见性，生物制药业投入资源研制新药的可能性即使最乐观估计也非常有限。但确定各种儿童癌症的潜在目标又离不开研究工作。在某些潜在目标领域，研发新的治疗方法需要展开公私合作。